Twitter As a Noninvasive Bio‐Marker for Trends in Liver Disease
Ben L. Da, Pallavi Surana, Samuel A. Schueler, Niloofar Y. Jalaly, Natasha Kamal, Sonia Taneja, Anusha Vittal, Christy L. Gilman, Theo Heller, Christopher Koh – 13 July 2019 – With the success of hepatitis C virus (HCV) direct‐acting antiviral therapies, there has been a shift in research focus to the other major chronic liver diseases (CLDs). The use of social media, specifically Twitter, has become a popular platform for understanding public health trends and for performing health care research.